News of the newly launched Global Ovarian Cancer Research Consortium — and its inaugural AI Accelerator Grant — is spreading quickly, with media outlets across the country taking notice.
The AI Accelerator Grant will award $1 million in funding, along with $1 million in compute support from Microsoft’s AI for Good Lab, to international research teams using artificial intelligence to advance ovarian cancer research. This bold initiative represents a significant step toward improving outcomes for patients worldwide.
Coverage has already aired on:
Additional press coverage coming soon – stay tuned for more.
The Consortium brings together leading ovarian cancer organizations — Ovarian Cancer Research Alliance in the United States, Ovarian Cancer Research Foundation (Australia), Ovarian Cancer Canada, and Ovarian Cancer Action (United Kingdom) in a collaborative effort to improve ovarian cancer survival rates.
